Similar Posts
Asia Mid-Session: US Dollar Whipsawed, Watch USD/JPY Key Resistance At 145.35
BySilas WUS stocks opened higher on Monday, 9 June, but pared gains in the second half after US-China trade talks in London concluded without progress. Talks are set to resume on Tuesday, 10 June. The S&P 500 (+0.1%) and Nasdaq 100 (+0.2%) posted modest gains, while the Russell 2000 outperformed (+0.6%). The Dow Jones Industrial Average…
FX Weekly Recap: February 2 – 6, 2026
BySilas WThe first full trading week of February delivered a volatile mix of central bank surprises, deteriorating labor market data, and sharp risk-off sentiment that upended traditional currency correlations. Australia’s Reserve Bank shocked markets with its first rate hike in over two years, propelling the Aussie to the week’s top performance, while the Japanese yen suffered…
AUD/USD faces pressure as weak labor data – ForexNews.PRO
BySilas WAussie Dollar Under Pressure Amid Economic Jitters Shifting focus to the AUD/USD pair, President Trump’s tariff policies continue to weigh on Aussie dollar demand. Given Australia’s trade-to-GDP ratio exceeds 50%, higher tariffs could disrupt global trade terms, dampening AUD/USD demand. On Thursday, weaker labor market data may have reflected tariff-related economic uncertainty. With 20% of…
Tesla (TSLA) Share Price Rises Ahead of Earnings Report
BySilas WOn 16 September, we noted signs of a strong market for Tesla (TSLA) shares, including:→ The price remaining above the psychological level of $400;→ Reaching the highest levels since late January. We also identified an ascending channel and suggested that the long-term outlook remained optimistic, although a correction could not be ruled out. Since then,…
GBP/USD –20.06.2025 – Orbex Forex Trading Blog
BySilas WGBP/USD –20.06.2025 – Orbex Forex Trading Blog XXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXX” width=”0″ style=”display:none;visibility:hidden”> Source link
iSTAR Medical’s MINIject® demonstrates significant sustained 5-year efficacy in treating glaucoma in STAR-GLOBAL trial
BySilas WFor immediate release iSTAR Medical’s MINIject® demonstrates significant sustained 5-year efficacy in treating glaucoma in STAR-GLOBAL trial Five-year safety profile including corneal health confirmed and 38% IOP reduction sustained Over 5000 patients benefiting from limited commercial rollout of MINIject® worldwide to-date iSTAR Medical to advance MINIject® independently following ending of AbbVie partnership WAVRE, Belgium —…

